LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Search

AdaptHealth Corp

Slēgts

SektorsVeselības aprūpe

9.48 -1.04

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

9.23

Max

9.61

Galvenie mērījumi

By Trading Economics

Ienākumi

-124M

-102M

Pārdošana

26M

846M

P/E

Sektora vidējais

17.527

66.845

Peļņas marža

-11.998

Darbinieki

10,900

EBITDA

-147M

24M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+28.96% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 5. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-88M

1.3B

Iepriekšējā atvēršanas cena

10.52

Iepriekšējā slēgšanas cena

9.48

Ziņu noskaņojums

By Acuity

50%

50%

154 / 351 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

AdaptHealth Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 6. marts 19:32 UTC

Iegādes, apvienošanās, pārņemšana

Diana Shipping Increases Offer to Acquire Genco -- Update

2026. g. 6. marts 17:44 UTC

Iegādes, apvienošanās, pārņemšana

Lonza to Offload Majority Stake in Capsule Business to Lone Star in $2.2 Billion Deal

2026. g. 6. marts 22:26 UTC

Galvenie ziņu notikumi

Why $100 Oil Is Now in Sight. Who Wins, Who Loses. -- Barrons.com

2026. g. 6. marts 22:07 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Boeing Says Spirit Acquisition Will Help Improve Safety -- Market Talk

2026. g. 6. marts 22:03 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 6. marts 22:03 UTC

Tirgus saruna

Boeing CEO's Pay Nears $24 Million During Recovery Phase -- Market Talk

2026. g. 6. marts 21:50 UTC

Tirgus saruna
Galvenie ziņu notikumi

Financial Services Roundup: Market Talk

2026. g. 6. marts 21:37 UTC

Peļņas

Salesforce Stock Might Not Be an AI Loser After All -- Barrons.com

2026. g. 6. marts 21:25 UTC

Galvenie ziņu notikumi

How The Iran War Impacts Ukraine. -- Barrons.com

2026. g. 6. marts 21:17 UTC

Peļņas

Burlington Stores' Strong Year Should Lift the Stock. What Comes Next. -- Barrons.com

2026. g. 6. marts 20:50 UTC

Peļņas

Marvell Stock Pops 20%. Semiconductor Earnings Show AI Demand Is Strong. -- Barrons.com

2026. g. 6. marts 20:46 UTC

Peļņas

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

2026. g. 6. marts 20:31 UTC

Galvenie ziņu notikumi

Oil Prices Soar Past $90. Trump Demands 'Unconditional Surrender' From Iran -- and Kuwait Cut Production. -- Barrons.com

2026. g. 6. marts 20:18 UTC

Tirgus saruna

Oil Makes Record Weekly Gains As Strait of Hormuz Stays Shut -- Market Talk

2026. g. 6. marts 20:12 UTC

Tirgus saruna
Galvenie ziņu notikumi

U.S. Natural Gas Futures Gain on Global Energy Turmoil -- Market Talk

2026. g. 6. marts 19:10 UTC

Tirgus saruna
Galvenie ziņu notikumi

$150 Oil Seen As Realistic If Hormuz Closure Lasts -- Market Talk

2026. g. 6. marts 18:54 UTC

Tirgus saruna

Fed's Hammack: Dollar Hasn't Lost Prime Status -- Market Talk

2026. g. 6. marts 18:44 UTC

Tirgus saruna
Galvenie ziņu notikumi

U.S. Oil Rig Count Increases By 4 to 411 -- Market Talk

2026. g. 6. marts 18:08 UTC

Peļņas

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

2026. g. 6. marts 18:04 UTC

Peļņas

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

2026. g. 6. marts 18:04 UTC

Peļņas

Samsara Stock Jumps 16% After Earnings. Why the CEO Isn't Worried About AI. -- Barrons.com

2026. g. 6. marts 17:49 UTC

Tirgus saruna

AI-Driven Picks-And-Shovels Bet Comes With Risks -- Market Talk

2026. g. 6. marts 17:46 UTC

Galvenie ziņu notikumi

Kuwait Cuts Oil Production as Fallout From Iran Conflict Intensifies -- Update

2026. g. 6. marts 17:40 UTC

Tirgus saruna
Peļņas

Marvell's Long-Term Outlook Well-Received By Investors -- Market Talk

2026. g. 6. marts 17:40 UTC

Peļņas

Marvell Stock Surges on Earnings. It's Not Just a Custom AI Chip Story. -- Barrons.com

2026. g. 6. marts 17:32 UTC

Tirgus saruna
Galvenie ziņu notikumi

No Quick Solution for Hormuz Shipping as U.S. Oil Tops $90 -- Market Talk

2026. g. 6. marts 17:28 UTC

Tirgus saruna
Galvenie ziņu notikumi

Aluminum Rising as Strait of Hormuz Stays Locked -- Market Talk

2026. g. 6. marts 17:20 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2026. g. 6. marts 17:20 UTC

Tirgus saruna
Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

2026. g. 6. marts 17:20 UTC

Iegādes, apvienošanās, pārņemšana

BlackRock Sticks to Redemption Minimum on Credit Fund, Sends Shares Lower -- WSJ

Salīdzinājums

Cenas izmaiņa

AdaptHealth Corp Prognoze

Cenas mērķis

By TipRanks

28.96% augšup

Prognoze 12 mēnešiem

Vidējais 12.38 USD  28.96%

Augstākais 14 USD

Zemākais 9.5 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi AdaptHealth Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

4 ratings

3

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

7.95 / 8.505Atbalsts un pretestība

Īstermiņā

Bullish Evidence

Vidējā termiņā

Strong Bearish Evidence

Ilgtermiņā

Strong Bearish Evidence

Noskaņojums

By Acuity

154 / 351 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par AdaptHealth Corp

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
help-icon Live chat